A protein knockdown strategy to study the function of beta-catenin in tumorigenesis.

TitleA protein knockdown strategy to study the function of beta-catenin in tumorigenesis.
Publication TypeJournal Article
Year of Publication2003
AuthorsCong F, Zhang J, Pao W, Zhou P, Varmus H
JournalBMC Mol Biol
Volume4
Pagination10
Date Published2003 Sep 29
ISSN1471-2199
KeywordsAnimals, beta Catenin, Cell Division, Cell Line, Tumor, Colorectal Neoplasms, Cytoskeletal Proteins, Mice, Mice, Nude, Protein Engineering, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Signal Transduction, Trans-Activators, Ubiquitins, Wnt Proteins, Zebrafish Proteins
Abstract

BACKGROUND: The Wnt signaling pathway plays critical roles in cell proliferation and cell fate determination at many stages of development. A critical downstream target of Wnt signaling is the cytosolic beta-catenin, which is stabilized upon Wnt activation and promotes transcription of a variety of target genes including c-myc and cyclin D. Aberrant Wnt signaling, which results from mutations of either beta-catenin or adenomatous polyposis coli (APC), renders beta-catenin resistant to degradation, and has been associated with multiple types of human cancers.

RESULTS: A protein knockdown strategy was designed to reduce the cytosolic beta-catenin levels through accelerating its turnover rate. By engineering a chimeric protein with the beta-catenin binding domain of E-cadherin fused to betaTrCP ubiquitin-protein ligase, the stable beta-catenin mutant was recruited to the cellular SCF (Skp1, Cullin 1, and F-box-containing substrate receptor) ubiquitination machinery for ubiquitination and degradation. The DLD1 colon cancer cells express wild type beta-catenin at abnormally high levels due to loss of APC. Remarkably, conditional expression of betaTrCP-E-cadherin under the control of a tetracycline-repressive promoter in DLD1 cells selectively knocked down the cytosolic, but not membrane-associated subpopulation of beta-catenin. As a result, DLD1 cells were impaired in their growth and clonogenic ability in vitro, and lost their tumorigenic potential in nude mice.

CONCLUSION: We have designed a novel approach to induce degradation of stabilized/mutated beta-catenin. Our results suggest that a high concentration of cytoplasmic beta-catenin is critical for the growth of colorectal tumor cells. The protein knockdown strategy can be utilized not only as a novel method to dissect the role of oncoproteins in tumorigenesis, but also as a unique tool to delineate the function of a subpopulation of proteins localized to a specific subcellular compartment.

DOI10.1186/1471-2199-4-10
Alternate JournalBMC Mol Biol
PubMed ID14516475
PubMed Central IDPMC222962
Grant ListR33 CA092792 / CA / NCI NIH HHS / United States
5R33-CA092792 / CA / NCI NIH HHS / United States
Related Lab: 
Related Faculty: 
Pengbo Zhou, Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700